Labcorp EBIT 2010-2024 | LH

Labcorp annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Labcorp EBIT for the quarter ending September 30, 2024 was $0.254B, a 0.71% increase year-over-year.
  • Labcorp EBIT for the twelve months ending September 30, 2024 was $0.747B, a 5.89% decline year-over-year.
  • Labcorp 2023 annual EBIT was $0.726B, a 49.49% decline from 2022.
  • Labcorp 2022 annual EBIT was $1.437B, a 52.88% decline from 2021.
  • Labcorp 2021 annual EBIT was $3.049B, a 24.67% increase from 2020.
Labcorp Annual EBIT
(Millions of US $)
2023 $726
2022 $1,437
2021 $3,049
2020 $2,445
2019 $1,330
2018 $1,326
2017 $1,305
2016 $1,271
2015 $997
2014 $904
2013 $991
2012 $1,024
2011 $948
2010 $979
2009 $936
Labcorp Quarterly EBIT
(Millions of US $)
2024-09-30 $254
2024-06-30 $295
2024-03-31 $321
2023-12-31 $-123
2023-09-30 $252
2023-06-30 $266
2023-03-31 $330
2022-12-31 $-54
2022-09-30 $374
2022-06-30 $429
2022-03-31 $688
2021-12-31 $520
2021-09-30 $767
2021-06-30 $704
2021-03-31 $1,058
2020-12-31 $1,293
2020-09-30 $1,047
2020-06-30 $298
2020-03-31 $-193
2019-12-31 $336
2019-09-30 $340
2019-06-30 $336
2019-03-31 $318
2018-12-31 $308
2018-09-30 $343
2018-06-30 $369
2018-03-31 $305
2017-12-31 $331
2017-09-30 $327
2017-06-30 $330
2017-03-31 $318
2016-12-31 $282
2016-09-30 $324
2016-06-30 $366
2016-03-31 $300
2015-12-31 $233
2015-09-30 $308
2015-06-30 $323
2015-03-31 $132
2014-12-31 $213
2014-09-30 $241
2014-06-30 $247
2014-03-31 $203
2013-12-31 $215
2013-09-30 $245
2013-06-30 $269
2013-03-31 $262
2012-12-31 $215
2012-09-30 $245
2012-06-30 $276
2012-03-31 $287
2011-12-31 $248
2011-09-30 $239
2011-06-30 $226
2011-03-31 $236
2010-12-31 $239
2010-09-30 $235
2010-06-30 $271
2010-03-31 $234
2009-12-31 $216
2009-09-30 $235
2009-06-30 $245
2009-03-31 $241
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.273B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.492B 21.23
Becton Dickinson (BDX) United States $66.954B 17.60
Cardinal Health (CAH) United States $29.177B 15.82
West Pharmaceutical Services (WST) United States $23.472B 47.94
Cooper (COO) United States $20.662B 29.41
Align Technology (ALGN) United States $16.462B 31.50
Henry Schein (HSIC) United States $8.478B 16.15
Merit Medical Systems (MMSI) United States $5.988B 30.58
DENTSPLY SIRONA (XRAY) United States $3.620B 9.65
CONMED (CNMD) United States $2.268B 18.93
Patterson (PDCO) United States $1.833B 9.67
STAAR Surgical (STAA) United States $1.458B 53.80
Lifevantage (LFVN) United States $0.171B 22.77
Pro-Dex (PDEX) United States $0.139B 27.71